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Feedback regulation of extracellular ATP-stimulated phosphoinositide
hydrolysis by protein kinase C-a in bovine glomerular endothelial cells.
In glomerular endothelial cells, extraeellular ATP stimulates a phospho-
lipase C with subsequent hydrolysis of polyphosphoinositides and an
increase in cytosolic free Ca2 concentration ([Ca2F]). Short-term (30
mm) pretreatment of endothelial cells with 12-O-tetradecanoylphorbol
13-acetate (TPA), a potent activator of protein kinase C (PKC), decreases
the ATP-stimulated phosphoinositide degradation and Ca2t mobilization.
However, this inhibition was lost after incubating the cells for four hours
with TPA. Longer-term pretreatment (10 to 48 hr) even potentiated
ATP-induced phosphoinositide breakdown and Ca2t mobilization. In
addition, pretreating the cells for 30 minutes with the specific PKC
inhibitor Ro 31-8220 dose-dependently increased ATP-stimulated phos-
phoinositide hydrolysis, thus clearly indicating a regulatory role for PKC in
the inositol lipid signaling pathway in glomerular endothelial cells. By
using specific antibodies recognizing the different PKC isoenzymes, it is
observed that glomerular endothelial cells express five isoenzymes:
PKC-a, -3, -€, - and -8. No PKC-$, -y, -ij and -j.t isoenzymes were
detected. On exposure to TPA, a complete depletion of PKC-a is observed
within four hours. In contrast, PKC-€ was more resistant to phorbol ester,
and even after 48 hours of TPA treatment, only 60% of PKC-€ was
down-regulated. PKC-8 decreased very slowly from the cytosol (47% left
after 24 hr of phorbol ester treatment) and translocated to the Triton
X100-insoluble fraction. Moreover, PKC-6 and PKC-C were not signifi-
cantly affected by 48 hours of phorbol ester incubation. Thus, only PKC-a
is depleted with a kinetic that corresponds to the loss of feedback
inhibition of ATP-stimulated phosphoinositide turnover. In the next step,
[Ca2I1 changes were measured in single cells loaded with Fura-2 after
microinjection of neutralizing PKC isoenzyme-specific antibodies. Injec-
tion of antibodies specific for PKC-a potently increased Ca2t mobilization
in response to ATP stimulation when compared to cells injected with
buffer only or antibodies specific for PKC-€. These results provide
evidence that PKC-a mediates feedback inhibition of ATP-stimulated
phosphoinositide hydrolysis in glomerular endothelial cells.
Glomerular capillary endothelial cells are highly specialized
cells that respond to a variety of vasoactive substances such as
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bradykinin, thrombin, ATP, and platelet-activating factor (PAP)
by releasing mediators like the vasoconstrictor endothelin or the
vasodilators prostacyclin and nitric oxide (NO) [1]. In coculture
experiments with glomerular mesangial cells, endothelial cells
have been shown to alter mesangial cell contractile function
and thus may contribute to the regulation of glomerular
filtration rate [2].
An increasing number of studies report that extracellular
nucleotides, like ATP and UTP, at low micromolar concentrations
can influence a variety of functions of intact cells [3]. In glomer-
ular endothelial cells, extracellular nucleotides mediate their
effects by a common nucleotide receptor that couples to phospho-
lipase C and triggers the formation of the two second messengers
inositol trisphosphate and 1,2-diacylglycerol [4]. This common
nucleotide receptor, also referred to as P2 receptor, has recently
been cloned and is a classical U-protein-coupled receptor with
only weak homology to the other known purinoceptors [5].
Purinoceptors have been classified by the rank order of potency of
ATP and its structural analogues in P1, P2, P2,, P2, P21, and P2
receptors [5, 6]. Whereas the P2 and P2 receptors are members
of the transmitter-gated ion channel superfamily of receptors, the
P2,, P2 and P21 receptors belong to the U-protein-coupled
receptor superfamily. Upon agonist binding, these latter purino-
ceptors are able to activate a phospholipase C with subsequent
activation of the two second messengers inositol trisphosphate
and 1,2-diacylglycerol. Inositol trisphosphate mobilizes Ca2t from
intracellular stores and 1,2 diacylglycerol activates a protein
kinase C (PKC). PKC has a dual role. On the one hand it
contributes positively to cellular responses, but equally important,
PKC also acts as a negative feedback regulator of phospholipasc
C activity, thus guaranteeing a finely tuned regulation of this
important signaling cascade [7, 81. Protein kinase C exists as a
family of at least 11 isoenzymes, all having related structures but
differing in tissue and cellular distribution and in their individual
enzymological characteristics [9—14].
In the present study, we report on the expression of PKC
isoenzymcs in bovine glomerular endothelial cells and provide
evidence for a role of PKC-a in feedback regulation of ATP-
stimulated phosphoinositide turnover.
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METHODS
Materials
TPA(12-O-tetradecanoyl phorbol 13-acetate) and 4a-phorbol
12,13-didecanoate were purchased from Calbiochem (Luzern,
Switzerland). Myo-[2-3H]inositol was from Amersham Interna-
tional (Buchs, UK) ATP and all cell-culture nutrients were from
Boehringer (Mannheim, Germany). All other chemicals used
were of high chemical grade.
Cell culture
Bovine glomerular endothelial cells were cultivated as de-
scribed previously [41. In brief, approximately 10 g of renal cortex
tissue were minced, passed through a sterile 240 jsm stainless steel
sieve, and suspended in HBSS. This suspension was then poured
through a 180 tm stainless sieve followed by a 100 jtm mesh. The
glomeruli retained by the 100 sm sieve were washed three times
in HBSS and were then incubated for 10 to 15 minutes at 37°C in
HBSS containing I mg/ml of collagenase (type V; Sigma Chemical
Co.). After digestion, glomerular remnants were sedimented at
500 g for five minutes. The supernatant was centrifuged at 1000 g
for five minutes, and the pellet was suspended in RPMI 1640
medium containing 20% FCS, penicillin (100 U/mI), streptomycin
(100 jig/mI), 50 jig/mI heparin sodium, and 5 ng/ml of acidic
fibroblast growth factor. Cells were plated on 0.2% gelatin-coated
tissue culture plates. Primary cultures of endothelial cell clones
were isolated with cloning cylinders, detached with trypsin-
EDTA, and passaged at cloning density onto gelatin-coated
35-mm diameter plates. Individual clones of endothelial cells were
characterized by positive staining for Factor Vill-related antigen
and uniform uptake of fluorescent acetylated low-density lipopro-
teins [1]. Negative staining for smooth muscle actin and cytoker-
atm excluded mesangial cell and epithelial cell contaminations.
For these experiments, passages 5 to 10 of endothelial cells were
used.
Determination of inositol phosphates
Subconfluent cells in 35 mm diameter dishes were labeled for
48 hours with myo-[2-3H]inositol (10 jiCi/ml) in RPMI 1640
medium free of inositol, containing 2% dialyzed fetal calf serum.
Phorbol esters or vehicle were added for the indicated time
periods. Thereafter, the medium was removed and the cells were
rinsed several times with Dulbecco's modified Eagle's medium
(DMEM) to remove free [3H]inositol, and incubated in 1 ml of
DMEM with or without ATP for 30 seconds. Thereafter the
reaction was terminated by rapid aspiration of the medium and
addition of I ml of 20% (wt/vol) trichloroacetic acid. For extrac-
tion of inositol phosphates the dishes were put on ice for one
hour. The trichloroacetic acid was then removed with diethyl
ether and the final extract was neutralized and applied to anion-
exchange columns containing 1 ml of Dowex 1-X8 (100 to 200
mesh, formate form; Serva, Heidelberg, Germany). Free inositol
and the inositol phosphates were eluted sequentially in accor-
dance with Berridge [15] as described previously [16]. Since
water-soluble [3H]inositol and its phosphorylated metabolites
were coprocessed in the separation assay, and thus should be
subjected to the same losses, the ratios of the phosphorylated
compounds relative to total water-soluble [3H]inositol were cal-
culated for each sample.
Peptide synthesis and generation of antibodies
Monoclonal anti-PKC-a (MC5) was from Amersham Interna-
tional, monoclonal anti-PKC-/3 and -y were from Seikagaku
Kogyo Co. (Tokyo, Japan) and were characterized as described
[17]. Synthetic peptides based on the C-terminal sequence of
PKC-h (KGFSFVNPKYEQFLE), PKC- (GFEYINPLLL-SAE-
ESV), PKC- (INQDEFRNFSYVSPELQL), PKC-ji (YETEE-
TEMKALGERVSIL), and a sequence of the D2-D3 domain of
PKC-e (residues 332-353: CVPTPGKREPQGISWDSPLDGSNK)
were synthesized on an AR! 431 peptide synthesizer, coupled to
keyhole-limpet hemocyanine by glutaraldehyde and used to im-
munize rabbits. The detailed characterization of anti-PKC -h, -€,
- and -sj antibodies are described in detail elsewhere [18—20].
The specificity of the antisera raised against the PKC-O and -ji
peptide immunogens were tested. Each antiserum recognized its
own antigen and failed to cross-react with any other PKC isoen-
zyme (data not shown). In addition, for detection of PKC-ji a
monoclonal antibody (kindly provided by Dr. Johannes, Stuttgart,
Germany) was used as well as a HELA cell extract for a positive
control [12].
Immunodetection of protein kinase C
Confluent endothelial cells in 150 mm diameter dishes were
washed with phosphate-buffered saline (PBS; 137 mM-NaCI/2.7
mM-KC1/8 mM-Na2HPO4/1.5 mM-KH2PO4) and incubated in
DMEM containing 0.1 mg of fatty-acid-free BSA/ml with or
without phorbol esters. After the indicated time periods, the
medium was removed. The cells were washed with ice-cold PBS
and scraped into 1 ml of ice-cold homogenization buffer (20
mM-TriS/HC1, pH 7.5, 1 mM-EDTAJ1 mM-EGTA!2 mM-dithio-
threitol/25 jig of leupeptin/ml/1 mM-phenylmethanesulphonyl flu-
oride/lO mtvi benzamidine/200 U of aprotinin/mI). All subsequent
steps were carried out at 4°C. The cells were lysed with 3 X 10
second bursts with a Branson B15 sonifier (setting 4.0) and
centrifuged for one hour at 100,000 g. Supernatants were used as
a source of cytosolic protein. Pellets were resonicated in 1 ml of
the same buffer containing 1% (vol/vol) Triton X-100 and recen-
trifuged, yielding the solubilized particulate fraction. The pellet
containing the Triton X-100 insoluble proteins was dissolved in
hot Laemmli buffer and loaded to gels. Protein concentration was
determined by the method of Bradford [21]. The PKC fractions
were subjected to SDS/PAGE (8% acrylamide gel) and proteins
were transferred on to nitrocellulose paper for one hour at 250
m. The blotting buffer used was 25 mtvi Tris/HC1, pH 7.4/190 mM
glycine in 20%/vol/vol) methanol. After the transfer, nitrocellu-
lose filters were washed extensively in distilled water and blocked
in blocking buffer [50 mrvt Tris/HC1, pH 7.5/200 mt NaCI/0.2%
(vol/vol) Triton X-100/3% (wt/vol) BSA/10% (vol/vol) horse
serum] for one hour at 25°C. Filters were then incubated for four
hours with monoclonal antibodies raised against the PKC-a, -13
and -y isoenzymes [171 or antiserum reactive with PKC-, -e,-,
-ii, -0, and - isoenzymes [18—20] (diluted in blocking buffer as
indicated in the legend of Fig. 2). After washing in buffer A [50
mM Tris/HCI, pH 7.5/200 mrvi NaC1/0.2% (vol/vol) Triton X-100;
4 X 5 mm], the filters were incubated for one hour with
horseradish-peroxidase conjugated anti-mouse IgG antibodies
(PKC-a, -/3 and -y) or anti-rabbit IgG antibodies (all other
isoenzymes), in blocking buffer. Thereafter, filters were washed
again (4 x 5 mm) in buffer A and finally, for color reaction the
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Fig. 1. Time course of TPA effects on ATP-stimulated inositol trisphos-
phate formation in glomerular endothelial cells. Cells were labeled with
myo- [3H]inositol, treated with TPA (500 nM) for the indicated time
periods and then exposed to ATP (100 LM) for 30 seconds. Inositol
trisphosphate (1P3) was determined as described in the Methods
section. Results are expressed as percentage of control values obtained
from ATP-stimulated control cells. Results are means SD of four
experiments. Significant differences from control: * < 0.05, by
Student's t-test.
filters were incubated in PBS containing 0.5 mg of 3,3'-diamino-
benzidine/ml and 0.03% H202 for 10 minutes and then washed
extensively in distilled water.
Microinjection and measurement of [Ca2*lj
{Ca2]1 was measured by using the fluorescent calcium indicator
Fura-2. Endothelial cells in 35 mm diameter dishes or on glass
cover slips, which were approximately 80% confluent, were incu-
bated for 30 minutes with 2 jIM Fura-2/AM in RPMI 1640
medium containing 10% FCS. Cells were then washed three times
with incubation buffer (135 mivi NaCl, 1 m'vi Na2HPO4, 10 mM
Hepes, 5 mM glucose, 2 mivi CaC12, 1 mrvi MgCl2, 5 mrvi KC1, pH
7.4) and used for direct [Ca2] measurements or subjected to
microinjection of antibodies specific for PKC isoenzymes a or
diluted in injection buffer (48 mivi K2HPO4, 4.5 mrvt KH2PO4, 14
mM NaH2PO, pH 7.2) using an automated capillary microinjec-
tion equipment (Zeiss AIS).
For routine [Ca2J1 measurements fluorescence (emission
wavelength 500 nm; excitation wavelengths 340 and 380 nm) was
measured at 37°C using a fluorescence photon counting machine
equipped with a computerized data analyzing system (Phocal;
Applied Imaging, Sunderland, UK). The maximal ratio was
measured after permeabilization of the cells with 5 >< 10 M digi-
tonin and the minimal ratio after chelating of the [Ca2] by 10 mrvi
tris(hydroxymethyl)aminomethane (Tris)-ethylene glycol-bis(-
aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) as de-
scribed [4].
Imaging of intracellular {Ca2]1 in single cells was carried out as
detailed in [22]. Fura-2 fluorescence was excited by twin, high-
pressure xenon arc lamps coupled to a rotating filter wheel and
interfaced to a Zeiss Axiovert 135 M inverted epi-fluorescence
microscope. Exitation wavelengths were set at 340 and 380 nm
and fluorescence emission was filtered at 510 nm and collected by
a Gen II intensified CCD camera (Photonic Science, Millham,
UK). The fluorescent images were analyzed using an image
processing system (ionVision 1,58; ImproVision Ltd., Coventry,
Table 1. Time course of TPA effects on ATP-induced increase in
[Ca2]1 in glomerular endothelial cells
Addition
Time of pretreatment with TPA
hours
Peak value of [Ca2]1
nM
Control 0 112 27
ATP 0 447±51
ATP 0.5 178 23
ATP 10 945 112
Cells were labeled with Fura-2/AM, treated with TPA (500 nM) for the
indicated time periods and then exposed to ATP (100 j.LM). Fluorescence
of cells was registered as described in the Methods section, and peak
values have been evaluated. Data are mean values SD of peak [Ca2}
from four experiments.
UK). Determination of [Ca2J was carried out using equation 5
of Grynkiewicz, Pienie and Tsien [23].
Using FITC-dextran (150 kDa molecular weight; Sigma) at a
concentration of 0.5% as a fluorescently labeled coinjection
marker ensured that all cells examined were equally well injected
with the different reagents used. FITC-dextran remains visible in
the cells longer than 48 hours and injected sample volumes can be
determined from the fluorescent signal [24].
RESULTS
Time course of TPA effects on ATP-stimulated phosphoinositide
hydrolysis and increase in [Ca2]1
Stimulation of glomerular endothelial cells prelabeled with
[3H]inositol by ATP (100 jIM) for 30 seconds caused marked
increases in formation of inositol monophosphate (+305%),
inositol bisphosphate (+ 137%) as well as in formation of inositol
trisphosphate (+ 112%), consistent with previously published data
[4]. Preincubation of glomerular endothelial cells with TPA (500
nM), a classical activator of PKC, for 30 minutes had no significant
effect on the basal inositolphosphates levels, but significantly
attenuated ATP-induced formation of inositolphosphates (Fig. 1).
However, this inhibition was no longer observed after incubating
endothelial cells for four hours with TPA (500 nM), as shown in
Figure 1. In contrast, longer-term pretreatment with TPA, that
causes down-regulation of PKC due to proteolytic degradation,
even lead to an enhanced ATP-induced generation of inositol-
phosphates (Fig. 1). The biologically inactive phorbol ester 4cs-
phorbol 12,13-didecanoate had no effect on ATP-induced
inositol phosphate formation (data not shown). As already
reported, ATP induced a pronounced transient increase in
[Ca2J in glomerular endothelial cells [4] that was potently
inhibited by 30 minutes of preincubation of the cells with TPA
(Table 1). By contrast, a 10 hour preincubation of the cells with
TPA caused an amplification of the nucleotide-stimulated
[Ca2]1 mobilization (Table 1).
Consistent with a negative-feedback control exerted by PKC,
the specific PKC inhibitor Ro 31-8220 [25] increased ATP-
stimulated inositol trisphosphate generation, as shown in Figure 2.
In the absence of ATP stimulation, Ro 3 1-8220 had no significant
effect on the basal level of inositol phosphates in endothelial cells.
PKC isoenzymes in glomerular endothelial cells
To determine the importance of PKC isoenzymes in the
regulation of phosphoinositide formation, we used isotype-spe-
cific antibodies for immuno-blotting procedures. Using monoclo-
nal antibodies recognizing PKC-a, -/3 and -y isoenzymes and
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Fig. 2. Effect of a specific PKC inhibitor, Ro 3 1-8220 on ATP-induced
inositol trisphosphate formation in glomerular endothelial cells. Cells
were labeled with myo-3H]inositoI, treated for 30 minutes with vehicle or
the indicated concentration of Ro 3 1-8220, and then exposed to ATP (100
ELM) for 30 seconds. lnositol trisphosphate levels (1P3) were determined as
described in the Methods section. Results are expressed as the percentage
of control values. Results are means SD of four experiments. Significant
differences from control: ** < 0.01, < 0.001, by Student's t-test.
Significant difference from ATP stimulation alone (without Ro 3 1-8220):
+P < 0.05, ++P < 0.01, by Student's t-tcst.
antisera reactive with PKC-h, -€,
-, -ii, -e and -j.r, we found that
glomerular endothelial cells expressed five PKC isoenzymes:
PKC-a, -h, -€, - and
-B (Fig. 3). No PKC-/3, -y, -and -p. could be
detected (data not shown). In unstimulated cells, PKC-a, -and -o
were predominantly present in the cytosolic fraction whereas
PKC-e was predominantly present in the particulate fraction, and
PKC- was equally distributed in the cytosolic and particulate
compartments (Fig. 3). Tn addition, the specific 72 kDa PKC-J3
antiserum we used recognized an approximately 80 kDa band in
the cytosolic fraction (Fig. 3). This band corresponded to PKC-a
antiserum cross-reacted material [26, 271. We believe that the
additional low molecular weight bands seen with the PKC-o
antiserum were likely to present degraded products of PKC-e [28].
Time-course of TPA-induced down-regulation of PKC
isoenzymes
Short-term treatment with TPA (500 nM) for up to one hour
resulted in an increase of membrane-bound PKC-a and -c and a
corresponding decrease of the isotypes in the cytosol, consistent
with a translocation of the isoenzymcs from the cytosolic to the
particulate fraction (Fig. 4). Longer-term incubation with TPA
resulted in a progressive decrease of PKC-a levels, with a
complete depletion after four hours. In contrast, down-regulation
of PKC -€ occurred at a much slower rate. After 24 hours of
incubation with TPA, there was still 50% of PKC-€ present in the
membrane that decreased to 35% after 48 hours (Fig. 4). Fur-
thermore, PKC-o decreased slowly from the cytosol upon phorbol
ester treatment. However there was no corresponding increase in
the particulate fraction, but rather an increase of PKC-O in the
Triton X100-insoluble fraction (Fig. 5). Moreover, PKC-6 and -
were not affected by phorbol ester treatment during the time
period of 48 hours.
Microinjection of antibodies specific for PKC-ce potentiated
ATP-stimulated Ca2 mobilization
From the time-course studies of TPA-induced down-regulation
of PKC isoenzymes, only PKC-a disappeared with kinetics that
corresponded to the loss of feedback inhibition of ATP-induced
inositol trisphosphate generation and [Ca2] mobilization. In the
next step, we microinjected mesangial cells with PKC isoenzyme-
specific neutralizing antibodies and measured Ca2 mobilization
in response to ATP stimulation. Previously we have reported that
inhibition of PKC or down-regulation of PKC results in a marked
potentiation of hormone-induced Ca2 mobilization in mesangial
cells [29, 30]. The possibility that loss of a distinct PKC isoenzyme
eliminates feedback inhibition of phosphoinositide turnover was
tested by specifically knocking out PKC-a and PKC-e by injecting
corresponding neutralizing antibodies into glomerular endothelial
cells. Only PKC-cs antibodies amplified ATP-induced intracellular
Ca2 F mobilization, which resulted in an enhanced Ca2 spike and
a prolonged elevation in [Ca2] (Fig. 6). Microinjection of PKC-€
specific antibodies or vehicle alone did not significantly alter the
ATP-stimulated changes in [Ca2].
DISCUSSION
Desensitization or adaptation is a widespread regulatory phe-
nomenon in which exposure of cells to different stimuli results in
a decreased cell responsiveness. Desensitization occurs in bacte-
ria, yeast, dictostelium and in higher eukaryotes, in hormone,
neurotransmitter and sensory systems. The early evolution of such
adaptive responses suggests that they are of fundamental physio-
logical importance. They protect the cells from information
overload and enable systems to respond repeatedly to external
signals.
A prominent and well characterized signaling pathway that is
stimulated by many hormones and is subjected to pronounced
desensitization is the degradation of phosphatidylinositol-4,5-
bisphosphate by phospholipase C, and the subsequent formation
of the important second messengers inositol trisphosphate and
diacylglycerol. Whereas inositol trisphosphate mobilizes Ca2
from intracellular stores, diacylglycerol serves to activate protein
kinase C. This enzyme then fulfills a dual task: it mediates the
cellular response to extracellular stimuli, but it also acts as a
negative feedback regulator, terminating cellular responsiveness
initiated by exposure to agonists [31].
In the kidney, the phosphoinositide signaling pathway is well
characterized in glomerular as well as in tubular cells [8, 29—34].
Previously, we have shown that in mesangial cells, negative
feedback regulation of angiotensin 11-induced phosphoinositide
hydrolysis is mediated by PKC [7]. This has subsequently been
confirmed in mesangial cells exposed to angiotensin II [35],
vasopressin [36], eicosanoids [37], extracellular nucleotides [34],
endothelin [38], bradykinin [39] and platelet-activating factor [40].
Comparable data have also been reported for glomerular epithe-
hal cells stimulated with ATP [41] or bradykinin [42] and in
medullary collecting tubule cells activated with epidermal
growth factor [31. Again, we were the first to extend these
studies on the level of individual PKC isoenzymes; we sug-
gested that PKC-cx is responsible for regulating phosphoinosi-
tide turnover, whereas PKC-€ is a candidate for stimulating
phospholipase A2 [18, 30].
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Fig. 3. Immunoblot analysis of PKC isoenzymes in glomerular endothelial cells. Confluent mesangial were harvested and the cytosolic and particulate
fractions were prepared as described in the Methods section. Samples (100 g of protein) were applied to SDSIPAGE, transferred to nitrocellulose,
and Western blot analysis was performed by using either monoclonal antibodies against PKC-a, -J3 and -y at a dilution of 1:100, or antisera reactive with
PKC-cS, -€, -, - (1:1000) and -0, - (1:100). Bands were detected with horseradish peroxidase. The molecular size markers used indicate 97.4 and 68
kDa values and the respective PKC isoenzymes are marked with arrowheads.
In glomerular endothelial cells, not much is known about these
signaling mechanisms since it has proven extremely difficult to
isolate and culture glomerular endothelial cells for functional in
vitro studies. Only a few groups have successfully reported on the
cultivation of glomerular endothelial cells [1, 4, 44].
In the present study, we investigated the PKC isoenzymes
expressed in glomerular endothelial cells and examined their
possible contribution to the regulation of agonist-stimulated
polyphosphoinositide turnover in this cell type. We used extracel-
lular ATP, an important endothelial cell agonist that has been
shown to trigger inositol trisphosphate generation and an intra-
cellular Ca2 mobilization in glomerular endothelial cells [4].
Short-term pretreatment of glomerular endothelial cells with the
phorbol ester TPA, the classical activator of PKC, inhibited
ATP-induced inositoiphosphate formation and mobilization of
[Ca21 as compared to control cells not treated with TPA. In
addition, pretreatment with the specific PKC inhibitor RO 31-
8220 [251 dose-dependently increased ATP-induced inositol-
phosphate formation, thus confirming the involvement of PKC
in the negative feedback regulation of this important signaling
pathway.
Moreover, after four hours of TPA pretreatment, the inhibition
of ATP-induced inositol trisphosphate generation was completely
lost, and longer-term pretreatment (10 to 48 hr) even lead to a
potentiation of agonist-stimulated polyphosphoinositide hydroly-
sis and [Ca21 increase. These data suggest that PKC exerts a
potent negative feedback regulation on ATP-induced phosphati-
dylinositol turnover that is lost after four hours of TPA treatment,
a regimen known to cause down-regulation of certain PKC
isoenzymes.
By using PKC isoenzyme-specific antibodies, we report for the
first time that glomerular endothelial cells express five PKC
isoforms, namely PKC-cs, -h, -e, -and -6. No PKC-j3, -y, - or-
could be detected. We also determined the down-regulation
kinetics of the different PKC isoforms upon phorbol ester treat-
ment in order to find a possible correlation with the time course
of removal of feedback regulation of ATP-induced polyphospho-
inositide hydrolysis and [Ca2] mobilization. As seen in Figure 4,
PKC-a is depleted within four to eight hours, and thus is a
possible candidate for the regulation of inositolphosphates for-
mation. PKC-E is only partially down-regulated even after 48
hours of TPA treatment, and thus can be excluded as a candidate
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Fig. 4. Immunoblot analysis of down-regulation of PKC isoenzymes in glomerular endothelial cells. Cells were teated with either vehicle for 10 minutes
(co) or TPA (500 nM) for the indicated time periods, and the cytosolic and particulate fractions were prepared as described in the Methods section.
Samples (100 g of protein) were applied to SDS/PAGE, transferred to nitrocellulose, and Western blot analysis was performed by using either a
monoclonal antibody against PKC-a at a dilution of 1:100 or antisera reactive with PKC-h, -€ and - at a dilution of 1:1000. Bands were detected with
horseradish peroxidase.
for feedback regulation of phosphoinositide turnover. PKC-5 and The finding that PKC-h does not translocate upon TPA treat-
PKC- are not down-regulated at all by TPA treatment, and ment suggests a cell-type-specific regulation of PKC-& in that
obviously do not contribute to the investigated cell response in PKC-b translocates and down-regulates upon TPA treatment in
endothelial cells. glomerular mesangial cell [19, 45], glomerular epithelial cells [45],
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Fig. 5. Translocation of PKC-O to the Triton-insoluble fraction. Glomer-
ular endothelial cells were stimulated with TPA (500 nM) for the indicated
time periods and the Triton-X100 insoluble proteins were obtained as
described in the Methods section. SDS/PAGE (8% acrylamide gel) was
performed and proteins were blotted onto nitrocellulose. Western blot
analysis was performed using a specific antiserum reactive with PKC-O at
a dilution of 1:200.
mouse epidermis [461 and COS cells [471 In contrast, no translo-
cation of the h-isoenzyme occurs in HCI I mouse mammary
epithelial cells [201, human dermal fibroblasts and keratinocytes
[48].
The unresponsiveness of PKC- towards TPA is well estab-
lished [19, 47] and most probably is due to the lack of the second
zinc-finger motif in the Cl domain of this isoenzyme.
PKC-e dissappeared very slowly from the cytosolic fraction
(47% after 24 hr). However, there was no increase in the
corresponding particulate fraction, but rather an accumulation of
PKC-O in the Triton X100-insoluhle fraction. Data from Osada et
al [28] revealed a prominent localization of PKC-O in a Triton
X100-insoluble fraction in COS-1 cells. These and our data may
suggest a role for PKC-O in cytoskeletal organization. However,
further experiments are necessary to elucidate such a possibility.
Taken together, our results demonstrate that only PKC-a is
depleted with a kinetics that corresponds sufficiently well to the
kinetics of loss of feedback inhibition of inositol trisphosphate
generation, thus suggesting that PKC-a is the most likely candi-
date responsible for regulation of phosphoinositide turnover in
glomerular endothelial cells.
We previously demonstrated that PKC-a exerts a comparable
regulatory function on hormone-stimulated phosphoinositide
turnover in glomerular mesangial cells [18, 301 and Ozawa et al
[49] reported that PKC-a and - isoenzymes negatively regulate
phospholipase C in rat basophilic RBL-2H3 cells. It therefore may
be speculated that this is a general function of PKC-a that occurs
in many cell types. The cellular target of PKC-a action responsible
for the inhibition of ATP-stimulated inositoiphosphates genera-
tion is not precisely known. Whether there is an alteration in
either the number of cellular receptors for ATP or in their affinity
has yet to be defined. Alternatively, PKC-a may inhibit the signal
transmission via the coupling G-protein or by directly affecting
PLC. In glomerular mesangial cells TPA treatment did not affect
guanosine 5'-[y-thio]triphosphate-induccd inositol trisphosphate
production from washed membranes of these cells [50], but
strongly decreased the synergistic effect of agonist on guanosine 5'
[y-thio]triphosphate-stimulated inositol trisphosphate formation,
Fig. 6. Effects of microinjection of PKC-a and -€ specific antisera on the
ATP-induced rise in [Ca2]1. Fluorescence of Fura-2 loaded endothelial
cells was registered and evaluated as described in the Methods section. At
time point 0 ATP (100 rM) wasadded to the cells. Data are mean values
so of [Ca211 from 3 to 6 experiments. Symbols are: (0) control; (•) cells
injected with anti-PKC-a antibodies; (A) cells injected with anti-PKC-€
antibodies.
thus suggesting that the coupling between the receptor and the
G-protein might be impaired [50].
Furthermore Kadata et al [51] and Yatomi et al [52] have
shown that PKC phosphorylates the a-subunit of the Gi-protein
and may thus interrupt signal flow. Alternatively, King and
Rittenhouse [53] suggested that PKC removes inositol trisphos-
phate by activating the 5-phosphomonoesterase and inositol
trisphosphate-3-kinase.
In conclusion, this is the first comprehensive investigation of the
complete panel of PKC isoenzymes in glomerular endothelial
cells, and we are the first to provide evidence on a specific
function of a distinct PKC isoenzyme in glomerular endothelial
cells. Further studies will be needed to evaluate the mechanism of
this important feedback mechanism and to identify the involved
substrates.
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